Published in

Springer, Journal of Neurology, 12(265), p. 2851-2860, 2018

DOI: 10.1007/s00415-018-9070-x

Links

Tools

Export citation

Search in Google Scholar

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.

Journal article published in 2018 by Mauro Zaffaroni, Elisabetta Signoriello, Gioacchino Tedeschi, Di Tommaso, Elena Tsantes, Antonio Uccelli, Luca Prosperini, Pietro Annovazzi, Laura Boffa, Maria Chiara Buscarinu, Antonio Gallo, Manuela Matta, Lucia Moiola, Luigina Musu, Paola Perini and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO